Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.
Department of Bioengineering, University of Washington, Seattle, WA, USA.
Methods Mol Biol. 2022;2485:87-97. doi: 10.1007/978-1-0716-2261-2_6.
Three-dimensional, human engineered heart tissue promotes maturation of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) and provides a useful platform for in vitro cardiac development and disease modeling. This protocol describes the generation of fibrin-based engineered heart tissues (EHTs) containing hiPSC-CMs and human stromal cells. The platform makes use of racks of silicone posts that fit a standard 24-well dish. Stromal cells and hiPSC-CMs are cast in a fibrin hydrogel suspended between two silicone posts, forming an engineered tissue that generates synchronous contractions. The platform described herein is amenable to various measures of cardiac function including measurement of contractile force and calcium handling, as well as molecular biology assays and immunostaining.
三维人工程心脏组织促进人诱导多能干细胞衍生的心肌细胞(hiPSC-CMs)的成熟,并为体外心脏发育和疾病建模提供了有用的平台。本方案描述了包含 hiPSC-CMs 和人基质细胞的纤维蛋白基工程心脏组织(EHT)的生成。该平台利用适合标准 24 孔板的硅树脂柱架。基质细胞和 hiPSC-CMs 被浇铸在纤维蛋白水凝胶中,该水凝胶悬浮在两个硅树脂柱之间,形成产生同步收缩的工程组织。本文所述的平台适用于各种心脏功能的测量,包括收缩力和钙处理的测量,以及分子生物学测定和免疫染色。